AFP and Cirrhosis: Current American Association for the Study of Liver Disease (AASLD) guidelines3 recommend biannual liver ultrasonography with or without serum alpha-fetoprotein (AFP) for at-risk patients with cirrhosis; however, ultrasound is not sensitive enough to detect early lesions, and the reported performance of AFP varies widely4.